Observing the natural progression of interstitial lung disease
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
This study is collecting data and blood samples from people with interstitial lung disease to see how the condition progresses over time and to better understand its effects.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT00470327 on ClinicalTrials.gov |
What this trial studies
This study aims to collect data and blood samples from patients diagnosed with interstitial lung disease (ILD) as well as a control group for comparison. By analyzing these samples, researchers hope to describe the phenotypic expression of various forms of ILD, including idiopathic pulmonary fibrosis and sarcoidosis. The observational nature of the study allows for a comprehensive understanding of disease progression without any specific interventions. This data will contribute to a better understanding of ILD and its impact on patients.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with interstitial lung disease.
Not a fit: Patients who do not have interstitial lung disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of interstitial lung diseases, leading to improved diagnosis and treatment strategies for patients.
How similar studies have performed: Other studies focusing on the natural progression of interstitial lung diseases have shown promise in understanding these conditions, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Interstitial lung disease Exclusion Criteria: * Does not have Interstitial lung disease
Where this trial is running
Chicago, Illinois
- University of Chicago — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Mary E Strek, MD — University of Chicago
- Study coordinator: Vanita Patel, MPH
- Phone: 773-702-1012
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.